Woman's health decline linked to cobalt poisoning from hip implant

A 58‑year‑old Ohio patient’s rapid weight loss, cardiac arrhythmia and neurological symptoms were traced to cobalt toxicity from a metal‑on‑metal hip replacement, highlighting ongoing safety gaps in orthopedic device design.

sources[Ars Technica][FDA][JAMA]

A 58‑year‑old woman in Ohio experienced six months of weight loss, fatigue, cardiac arrhythmia and neurological symptoms before clinicians identified cobalt poisoning from her metal‑on‑metal hip replacement as the cause [Ars Technica][FDA].

The implant, a DePuy ASR cobalt‑chrome cup mated to a metal femoral head, was placed in 2014. In March 2026 her serum cobalt level measured 152 µg/L—well above the 5 µg/L threshold linked to systemic toxicity. Imaging showed a grey fluid collection around the prosthesis and necrotic tissue from metal wear debris. Revision surgery in May removed 30 g of metallic debris and revealed extensive taper‑junction corrosion. Post‑operative cobalt fell to 7 µg/L and her cardiac rhythm normalized within two weeks. The case mirrors a 2025 FDA safety communication that logged over 1,200 adverse event reports for cobalt‑chrome hip devices since 2010 [FDA].

Why it matters: metal‑on‑metal designs remain a hidden hazard despite the 2012 recall of several ASR models; newer generations still use cobalt‑chrome alloys, and the FDA continues to receive reports of elevated cobalt levels and systemic effects. Cobalt‑chrome’s susceptibility to fretting at modular junctions drives ion release that bypasses local tissue barriers—a risk documented in a 2024 JAMA study of 45 patients with similar implants [JAMA]. Finally, current post‑market surveillance relies on voluntary adverse‑event submissions, allowing toxicity to go undetected until severe organ damage occurs.

Editor’s take

Persisting cobalt‑chrome bearings reflect an outdated design philosophy. Ceramic‑on‑ceramic and metal‑on‑polyethylene configurations deliver comparable wear performance without systemic metal exposure. Continuing to market metal‑on‑metal implants invites avoidable health crises and erodes trust in medical‑device engineering. The industry should pivot to corrosion‑free alloys and embed routine ion‑level testing into post‑implant care.

Reader poll

Which hip‑implant material do you trust for long‑term safety?